People In Brief
This article was originally published in The Tan Sheet
Fluxome CEO Tsetsis has omega-3 development experience; smoking cessation firm CN Creative names Byrne CFO; Perrigo adds formulation scientist Ma to N.J. facility; NOW Foods promotes COO Emme to president; NBA coach Silas endorses Clotamin; more People In Brief.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.